Search Results for hemophilia

Product: Ceveron® TGA RB Kit

Product: Chromogenix Coamatic® Factor VIII

Product: REAADS vWF Antigen

Product: Rox Factor VIII

Product: Technoclone Factor IX Deficient Plasma, Native

Product: Technoclone Factor IX Deficient Plasma, Native

Product: Technoclone Factor VIII Deficient Plasma, Native

Product: Technoclone Factor VIII Deficient Plasma, Native

Product: Technoclone Factor VIII INH Plasma, HCV Negative

Product: Technoclone Siron LIS (aPTT liquid), 10x10ml

Product: Technoclone Siron LIS (aPTT liquid), 10x4ml

Product: Technoclone Siron LIS (aPTT liquid), 2x4ml

Product: Technoclone Siron LS (aPTT liquid), 10x10ml

Product: Technoclone Siron LS (aPTT liquid), 10x4ml

Product: Technoclone Siron LS (aPTT liquid), 2x4ml

Page:

Page: Activated Protein C (APC) and Factor V Leiden

Page: Assays for your Gene Therapy Research in Rare Diseases

Page: Clot Club

Page: Clot Club - Here The Clot Thickens

Page: COMPREHENSIVE PRIMARY HEMOSTASIS ASSESSMENTS TO DIAGNOSE AND MONITOR VWD

Page: DiaPharma - We Deliver Solutions

Page: DiaPharma in the community

Page: Factor IX (FIX)

Page: Factor VIII (FVIII)

Page: Factor XI (FXI)

Page: Factor XIII (FXIII)

Page: Hemophilia

Page: HOW TO MONITOR HEPARIN THERAPY. STILL A CONTROVERSY?

Page: HTRS 2019 Conference Summary

Page: ISTH 2020

Page: ISTH 2023 Blog Compilation

Page: It’s Not Just Support. It’s Solutions.

Page: Laboratory Tests for von Willebrand Factor (VWF)

Page: TAFI (Thrombin-Activatable Fibrinolysis Inhibitor)

Page: THE NEW NOVEL ANTICOAGULANTS XI(a) and XII(a). THE CONTACT FACTOR INHIBITORS: Battling thromboembolism.

Page: Thrombin Generation

Page: THSNA 2020 Virtual Meeting

Page: THSNA 2022 Recap

Page: von Willebrand Disease

Page: von Willebrand Factor (vWF)

News: 27th Congress of the International Society of Thrombosis and Haemostasis and 65th Annual Scientific and Standardization Committee (SSC) (ISTH 2019)

News: 2nd Annual Hemophilia Drug Development (HDD) Summit

News: Assays Available from Diapharma

News: Assays for your Gene Therapy Research in Rare Diseases

News: Chromogenic Factor VIII and FIX Assays For Hemophilia Studies

News: Chromogenic Factor VIII and FIX Assays for Hemophilia Studies

News: Chromogenic FVIII and FIX Assays for Hemophilia Studies

News: Clot Club #1

News: Connect with DiaPharma at ASH 2022 in New Orleans

News: Cost Savings of APC Resistance Screening

News: Hemostasis & Thrombosis Research Society (HTRS) Scientific Symposium 2017

News: Hemostasis Gordon Research Conference (GRC): Defining the Interactions Between Blood, Cells, and Vessels in Hemostasis and Disease

News: Next Generation Assays for Hemophilia A & B Gene Therapy Research

News: On Sale! APC Resistance V (FV Leiden) and Chromogenic FVIII Kits

News: On Sale! APC™ Resistance V (FV Leiden) Kits

News: Thank you for visiting us at THSNA 2018!

News: University of North Carolina at Chapel Hill Center for Thrombosis and Hemostasis 9th Symposium on Hemostasis

News: What's New at Diapharma?

News: What's New at Diapharma? Our Team is Expanding!

News: WHD 2023

News: World Hemophilia Day

News: World Hemophilia Day

News: World Hemophilia Day

News: World Hemophilia Day

News: XXV Congress of the International Society on Thrombosis and Haemostasis (ISTH) and 61st Annual SSC Meeting

News: XXVI International Society of Thrombosis and Hemostasis (ISTH) Congress 2017 and 63rd Annual Scientific and Standardization Committee (SSC)

News: XXXII International Congress of the World Federation of Hemophilia (WFH)

News: YOUR SOURCE FOR HEMOPHILIA CLINICAL AND RESEARCH SOLUTIONS

Faq: We know that low levels of factor VIII activity constitutes hemophilia A, but are there any clinical manifestations of elevated factor VIII levels? How can a researcher measure elevated FVIII levels?

Faq: What are FVIII inhibitors, and how can I measure them?

Faq: Who can benefit from using chromogenic factor VIII assays?